Thalidomide dosing in patients with relapsed or refractory multiple myelomaTHOMPSON, Jennifer L; HANSEN, Lea Ann.The Annals of pharmacotherapy. 2003, Vol 37, Num 4, pp 571-576, issn 1060-0280, 6 p.Article

The treatment of multiple myeloma with docetaxel (an ECOG study)FRIEDENBERG, William R; GRAHAM, David; GREIPP, Philip et al.Leukemia research. 2003, Vol 27, Num 8, pp 751-754, issn 0145-2126, 4 p.Article

Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myelomaHEDVAT, Cyrus V; COMENZO, Raymond L; TERUYA-FELDSTEIN, Julie et al.British journal of haematology. 2003, Vol 122, Num 5, pp 728-744, issn 0007-1048, 17 p.Article

Wnt signaling in B-cell neoplasiaQIANG, Ya-Wei; ENDO, Yoshimi; RUBIN, Jeffrey S et al.Oncogene (Basingstoke). 2003, Vol 22, Num 10, pp 1536-1545, issn 0950-9232, 10 p.Article

Cell context reveals a dual role for Maf in oncogenesisPOUPONNOT, C; SII-FELICE, K; HMITOU, I et al.Oncogene (Basingstoke). 2006, Vol 25, Num 9, pp 1299-1310, issn 0950-9232, 12 p.Article

Brazilin Induces Apoptosis and G2/M Arrest via Inactivation of Histone Deacetylase in Multiple Myeloma U266 CellsKIM, Bonglee; KIM, Sun-Hee; JEONG, Soo-Jin et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 39, pp 9882-9889, issn 0021-8561, 8 p.Article

Nonsecretory multiple myeloma: presenting findings, clinical course and prognosisCAVO, M; GALIENI, P; GOBBI, M et al.Acta haematologica. 1985, Vol 74, Num 1, pp 27-30, issn 0001-5792Article

Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic FormRAGO, Angela; GRAMMATICO, Sara; LA VERDE, Giacinto et al.Cancer. 2012, Vol 118, Num 22, pp 5544-5549, issn 0008-543X, 6 p.Article

Influencing the Wnt Signaling Pathway in Multiple MyelomaKIM, Young; REIFENBERGER, Guido; DESHENG LU et al.Anticancer research. 2011, Vol 31, Num 2, pp 725-730, issn 0250-7005, 6 p.Article

Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cellsBRITO, Jose L. R; DAVIES, Faith E; GONZALEZ, David et al.Journal of immunological methods. 2008, Vol 333, Num 1-2, pp 147-155, issn 0022-1759, 9 p.Article

La maladie de Kahler = MyelomaDUPONT, T; GOMEZ, J; CUVILLIER, P et al.Médecine interne (Paris). 1983, Vol 18, Num 4, pp 190-196, issn 0025-6781Article

Characterization of polyclonal autoantibodies specific for β2-microglobulin in multiple myeloma seraVINCENT, C; REVILLARD, J.-P; BATAILLE, R et al.Clinical and experimental immunology (Print). 1983, Vol 54, Num 3, pp 689-696, issn 0009-9104Article

Clinical observations showing the role of some factors in the etiology of multiple myelomaAKSOY, M; ERDEM, S; DINCOL, G et al.Acta haematologica. 1984, Vol 71, Num 2, pp 116-120, issn 0001-5792Article

A pitfall in MRIABE, Kazuo; HIKITA, Tachio; YOKOE, Masaru et al.Internal medicine (Tokyo. 1992). 2004, Vol 43, Num 5, issn 0918-2918, p. 447Article

Les myélomes à IgD. A propos d'une observation personnelle = IgD myelomas. About one personnal observationLUTRINGER, B; SUSSMANN, J; KUNTZ, J. L et al.Journal de médecine de Strasbourg. 1984, Vol 15, Num 3, pp 149-153, issn 0021-7905Article

Méningite plasmocytaire au cours d'un myélome multiple. Observation anatomo-clinique = Plasma cell meningitis in multiple myeloma. A clinical and pathologic studyBOUDOURESQUES, G; PELLISSIER, J. F; GASTAUT, J. A et al.Annales de médecine interne (Paris). 1983, Vol 134, Num 2, pp 117-122, issn 0003-410XArticle

Peripheral blood stem-cell transplantation intensive treatment of multiple myelomaREIFFERS, J; MARIT, G; BOIRON, J.-M et al.Lancet (British edition). 1989, Vol 2, Num 8675, issn 0140-6736, 1336Article

Half body radiation in plasma cell myeloma = L'irradiation hémicorporelle dans le myélomeROWLAND, C. G; GARRETT, M. J; CROWLEY, F. A et al.Clinical radiology. 1983, Vol 34, Num 5, pp 507-510, issn 0009-9260Article

Prognostic value of the staging system proposed by Merlini, Waldenstöm and Jayakar for multiple myelomaBETTINI, R; STEIDL, L; RAPAZZINI, P et al.Acta haematologica. 1983, Vol 70, Num 6, pp 379-385, issn 0001-5792Article

Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC)ABDALLA, A. O; KOKHAEI, P; HANSSON, L et al.Annals of oncology. 2008, Vol 19, Num 6, pp 1172-1179, issn 0923-7534, 8 p.Article

An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis : The revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005)OTSUYAMA, Ken-Ichiro; ASAOKU, Hideki; KAWANO, Michio M et al.International journal of hematology. 2006, Vol 83, Num 1, pp 39-43, issn 0925-5710, 5 p.Article

In pursuit of the allo-immune response in multiple myeloma : where do we go from here?COOK, G; BIRD, J. M; MARKS, D. I et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 2, pp 91-99, issn 0268-3369, 9 p.Article

Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell linesXIN LI; PENNISI, Angela; FENGHUANG ZHAN et al.British journal of haematology. 2007, Vol 138, Num 6, pp 802-811, issn 0007-1048, 10 p.Article

Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma : emphasis on risk factors for progressionKYLE, Robert A; RAJKUMAR, S. Vincent.British journal of haematology. 2007, Vol 139, Num 5, pp 730-743, issn 0007-1048, 14 p.Article

Comparative genomic hybridisation identifies two variants of smoldering multiple myelomaROSINOL, Laura; CARRIO, Ana; BLADE, Joan et al.British journal of haematology. 2005, Vol 130, Num 5, pp 729-732, issn 0007-1048, 4 p.Article